Article
Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology.
Stem cell research & therapy - 2 Sept 2022
Umbach Alessandro, Maule Giulia, Kheir Eyemen, Cutarelli Alessandro, Foglia Marika, Guarrera Luca, Fava Luca L, Conti Luciano, Garattini Enrico, Terao Mineko, Cereseto Anna
Abstract excerpt
BACKGROUND: Cornelia de Lange syndrome (CdLS) is a rare multisystem genetic disorder which is caused by genetic defects involving the Nipped-B-like protein (NIPBL) gene in the majority of clinical cases (60-70%). Currently, there are no specific cures available for CdLS and clinical management is needed for life. Disease models are highly needed to find a cure. Among therapeutic possibilities are genome editing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
